Gildan Slashes 2026 Guidance, Withdraws Long-Term Targets as Q3 Sales Miss
GIL is trading near its 52-week low of $39.15 (11% below the low).
Summary
Gildan reported Q3 sales of $1.47 billion, missing its ~$1.65 billion guidance, and cut full-year 2026 revenue and EPS guidance sharply while withdrawing its 2026-2028 targets. A new buyback for up to 5% of shares and a $0.249 dividend were also announced.
Key Events · Earnings and Guidance · GIL
-
Q3 Sales Miss and Guidance Cut
Q3 net sales from continuing operations were $1.47 billion, up 61.1% year over year but below guidance of approximately $1.65 billion. Full-year 2026 revenue guidance was cut to $5.4-5.5 billion from $6.0-6.2 billion.
-
EPS Outlook Reduced ~20%
Adjusted diluted EPS guidance falls to $3.70-3.80 from $4.65-4.75, and adjusted operating margin to approximately 20% from approximately 21.8%. Free cash flow guidance drops to $700-750 million from approximately $1.0 billion.
-
Long-Term Targets Withdrawn
Citing rapid change in macroeconomic conditions, the company withdrew its previously communicated 2026-2028 objectives and intends to provide an updated long-term outlook at an Investor Day in spring 2027.
-
New 5% Buyback Approved
The board approved a new NCIB to repurchase up to 9,260,156 common shares, about 5% of the 185,203,126 shares outstanding as of October 30, 2026, commencing November 9, 2026 and running until November 8, 2027.
Analysis · GIL · Manufacturing
The guidance reset is the dominant fact here, and it is severe: Q3 revenue of $1.47 billion fell well short of the company's own ~$1.65 billion guidance, and management now expects the demand weakness to persist into Q4. Full-year revenue guidance drops to $5.4-5.5 billion from $6.0-6.2 billion, adjusted EPS to $3.70-3.80 from $4.65-4.75, and free cash flow to $700-750 million from ~$1.0 billion — roughly a 20% cut to the earnings outlook. Management also withdrew its 2026-2028 objectives entirely, removing the long-term framework investors were underwriting, and pushed a replacement outlook to an Investor Day planned for spring 2027. Against that, the new NCIB for up to 5% of shares and the $0.249 dividend show capital returns resuming, but buybacks are discretionary and leverage at 2.7x sits above the 1.5-2.5x target. With the stock already near its 52-week low, the guidance reset is the dominant fact.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GIL was trading at $35.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $8B. The 52-week trading range was $39.15 to $73.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.